-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SVj1M19tJFS1uz/PHpzD4OjDg50pwa8EJjf9Kcy7hCB5pBa9pOTFlvNh+c3oORYg OL7G4NGHkMiWeNAQZyzzqg== 0000944209-97-000499.txt : 19970421 0000944209-97-000499.hdr.sgml : 19970421 ACCESSION NUMBER: 0000944209-97-000499 CONFORMED SUBMISSION TYPE: POS AM PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19970418 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: SYNBIOTICS CORP CENTRAL INDEX KEY: 0000719483 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 953737816 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: POS AM SEC ACT: 1933 Act SEC FILE NUMBER: 033-68250 FILM NUMBER: 97583332 BUSINESS ADDRESS: STREET 1: 11011 VIA FRONTERA CITY: SAN DIEGO STATE: CA ZIP: 92127 BUSINESS PHONE: 6194513771 POS AM 1 POST-EFFECTIVE AMENDMENT NO. 1 As filed with the Securities and Exchange Commission on April 18, 1997 Registration No. 33-68250 =============================================================== U.S. SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ----------------------- POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SYNBIOTICS CORPORATION (Name of registrant as specified in its charter) California 95-3737816 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 11011 Via Frontera San Diego, California 92127 (Address of principal executive offices) (Zip Code) KENNETH M. COHEN PRESIDENT AND CHIEF EXECUTIVE OFFICER SYNBIOTICS CORPORATION 11011 VIA FRONTERA, SAN DIEGO, CALIFORNIA 92127 (Name and address of agent for service) (619) 451-3771 (Telephone number, including area code, of agent for service) Copies to: HAYDEN J. TRUBITT, ESQ. BROBECK, PHLEGER & HARRISON 550 West C Street, Suite 1300 San Diego, California 92101 ----------------------- Approximate date of commencement of proposed sale to the public From time to time after the effective date of this Registration Statement ----------------------- If the only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box:[_] If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans, check the following box: [X] If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering: [_] If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering: [_] If delivery of the prospectus is expected to be made pursuant to Rule 434, please check the following box: [_] ================================================================================ SYNBIOTICS CORPORATION Deregistration -------------- This Registration Statement, as amended to the date of its effectiveness (September 23, 1993), registered 530,303 shares of the Common Stock of Synbiotics Corporation (the "Company"). These shares (the "Shares") were offered for resale by PruTech Research and Development Partnership II ("PruTech"), who received such Shares in connection with the termination of certain agreements with the Company. PruTech sold 409,800 of the shares as described in the "Plan of Distribution" in the Registration Statement. PruTech and the Company have agreed to deregister all the unsold Shares at this time. PruTech may continue to sell such Shares as may be permitted by Rule 144(k). Accordingly, the Company hereby deregisters 120,503 shares of the Common Stock originally covered by the Registration Statement. II-1 SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Company has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Diego, State of California, on this 18th day of April, 1997. SYNBIOTICS CORPORATION By /s/ KENNETH M. COHEN ------------------------------------- Kenneth M. Cohen President and Chief Executive Officer
SIGNATURE TITLE DATE - --------- ----- ---- /s/ KENNETH M. COHEN Chief Executive Officer, President and Director April 18, 1997 - ----------------------- Kenneth M. Cohen (Principal Executive Officer) /s/ MICHAEL K. GREEN Chief Financial Officer Vice President - Finance April 18, 1997 - ----------------------- Michael K. Green (Principal Financial Officer) /s/ KEITH A. BUTLER Chief Accounting Officer and Corporate Controller April 18, 1997 - ----------------------- Keith A. Butler (Principal Accounting Officer) /s/ PATRICK OWEN BURNS Director April 18, 1997 - ----------------------- Patrick Owen Burns /s/ JAMES C. DECESARE Director April 18, 1997 - ----------------------- James C. DeCesare /s/ BRENDA D. GAVIN Director April 18, 1997 - ----------------------- Brenda D. Gavin /s/ M. BLAKE INGLE Director April 18, 1997 - ----------------------- M. Blake Ingle /s/ DONALD E. PHILLIPS Director April 18, 1997 - ----------------------- Donald E. Phillips
II-2 -----END PRIVACY-ENHANCED MESSAGE-----